Učitavanje...

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Patients with non-small cell lung cancer (NSCLC) who harbor anaplastic lymphoma kinase (ALK) gene rearrangements can derive significant clinical benefit from ALK tyrosine kinase inhibitor. Accurate patient identification is absolutely crucial for successful using ALK inhibitor treatment. However, lu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Lung Cancer Res
Glavni autori: Kim, Hyojin, Chung, Jin-Haeng
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384218/
https://ncbi.nlm.nih.gov/pubmed/25870797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.12.02
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!